Astral Codex Ten Podcast cover image

Response To Alexandros Contra Me On Ivermectin

Astral Codex Ten Podcast

00:00

Blinertumumab Trial - A Comparison of Vaccines and Controls

The requirement of rigorous eligibility criteria in the Blinertumumab clinical study, such as Eastern Cooperative Ontology Group status of two or lower and absence of abnormal lab values during screening, may increase the chances of better outcomes. Scott writes, Compare this to how the Barodis study discusses its synthetic control group. The control data was from contemporary infected subjects in Australia obtained from published COVID tracking data. In Barodiet L synthetic control group 70 of 600 that's 11.5% of patients required hospitalization. But the US hospitalization rate appears to be about 1% for unvaccinated individuals. This seems very relevant to this study finding that Ivermectin decreases hospital

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app